Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$6.39 - $28.58 $539,955 - $2.42 Million
84,500 Added 650.0%
97,500 $649,000
Q1 2023

May 15, 2023

BUY
$17.7 - $33.24 $230,100 - $432,120
13,000 New
13,000 $242,000
Q2 2021

Aug 16, 2021

SELL
$29.06 - $38.83 $1.16 Million - $1.55 Million
-40,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$39.04 - $64.6 $618,510 - $1.02 Million
15,843 Added 65.58%
40,000 $1.73 Million
Q4 2020

Feb 16, 2021

BUY
$42.46 - $56.58 $388,806 - $518,103
9,157 Added 61.05%
24,157 $1.12 Million
Q3 2020

Nov 16, 2020

BUY
$37.44 - $64.63 $561,600 - $969,449
15,000 New
15,000 $650,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $14.3M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.